Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

GM1 ganglioside is protective in alpha-synuclein model of Parkinson's disease

Aug. 19, 2019

In dopamine D1 receptor combo, ghrelin is resurrected as Alzheimer's target

Aug. 16, 2019

New dopamine D3 receptor antagonists synthesized at Shionogi

Aug. 16, 2019

H3R inverse agonist LML-134 demonstrates rapid brain penetration and fast kinetic profile

Aug. 16, 2019

TNFR2 is yang to TNFR1's yin

Aug. 16, 2019

Too much oxygen may be issue in Leigh syndrome

Aug. 14, 2019

AC Immune partners with University of Pennsylvania to further study TDP-43

Aug. 14, 2019

DS-39201083 is a new derivative of conolidine with superior analgesic activity

Aug. 14, 2019

New mGluR5 allosteric modulators discovered at Recordati Industria Chimica e Farmaceutica

Aug. 14, 2019

New beta-secretase inhibitors synthesized at Novartis

Aug. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...